Ivivi Technologies (OTCMKTS:IVVI) and Varian Medical Systems (NYSE:VAR) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, dividends, earnings, profitability, valuation, institutional ownership and risk.
Institutional and Insider Ownership
87.0% of Varian Medical Systems shares are held by institutional investors. 31.2% of Ivivi Technologies shares are held by insiders. Comparatively, 0.8% of Varian Medical Systems shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Profitability
This table compares Ivivi Technologies and Varian Medical Systems' net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
---|
Ivivi Technologies | N/A | N/A | N/A |
Varian Medical Systems | 8.50% | 18.45% | 8.08% |
Analyst Recommendations
This is a summary of current ratings for Ivivi Technologies and Varian Medical Systems, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
---|
Ivivi Technologies | 0 | 0 | 0 | 0 | N/A |
Varian Medical Systems | 3 | 5 | 0 | 0 | 1.63 |
Varian Medical Systems has a consensus target price of $159.3571, suggesting a potential downside of 10.00%. Given Varian Medical Systems' higher possible upside, analysts plainly believe Varian Medical Systems is more favorable than Ivivi Technologies.
Earnings & Valuation
This table compares Ivivi Technologies and Varian Medical Systems' revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
---|
Ivivi Technologies | N/A | N/A | N/A | N/A | N/A |
Varian Medical Systems | $3.17 billion | 5.13 | $269.20 million | $3.91 | 45.29 |
Varian Medical Systems has higher revenue and earnings than Ivivi Technologies.
Summary
Varian Medical Systems beats Ivivi Technologies on 6 of the 7 factors compared between the two stocks.